Skip to main content

Carlos Suso Ribera

Institutions of which they are part

Postdoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Carlos Suso Ribera

Institutions of which they are part

Postdoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Lidia Estepa Hombrados

Lidia Estepa Hombrados

Postdoctoral researcher
Pneumology
Read more
Sergi Torramadé Moix

Sergi Torramadé Moix

Postdoctoral researcher
Transfusional Medicine
Read more
Sara Palacin i Bonson

Sara Palacin i Bonson

Research technician
Neurodegenerative Diseases
Read more
Frederic Pons Pellicer

Frederic Pons Pellicer

Administration and Management
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.